Data / Form D filings / 28bio, Inc.
28bio, Inc.: Form D filings
28bio, Inc., a biotechnology company in Metairie, LA, filed 7 Form D notices with the SEC between 2019 and 2026. The latest, on October 29, 2026, reports $8.5 million sold of a $8.5 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4224 HOUMA BLVD., SUITE 224, Metairie, LA, 70006
- Phone
- (504) 407-7419
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1769360
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | Amendment | $8,524,945 | $8,524,945 | 10 | May 21, 2025 | sec.gov | |
| Jan 27, 2026 | Amendment | $7,000,000 | $6,525,000 | $475,000 | 8 | May 21, 2025 | sec.gov |
| Jun 24, 2025 | New notice | $5,000,000 | $1,775,000 | $3,225,000 | 2 | May 21, 2025 | sec.gov |
| Nov 22, 2024 | New notice | $4,751,652 | $3,684,771 | $1,066,881 | 21 | Nov 8, 2024 | sec.gov |
| Jun 10, 2021 | Amendment | $6,056,462 | $6,056,462 | 12 | Jun 2, 2020 | sec.gov | |
| Jun 15, 2020 | New notice | $3,765,996 | $1,965,997 | $1,799,999 | 7 | Jun 2, 2020 | sec.gov |
| Mar 5, 2019 | New notice | $2,500,000 | $1,133,000 | $1,367,000 | 13 | Feb 19, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alif Saleh | Executive Officer, Director | |
| David Weiner | Director | |
| Dale Pfost | Director | |
| Michael Katz | Director | |
| Miklos Kobor | Director | |
| Paul Friel | Director |
Other biotechnology companies in Louisiana that filed recently
- Therapeutic Neuromodulation Systems LLC $1.7 million · Sep 21, 2026
- QUICKTAKE HEALTH CO $2.1 million · Aug 6, 2026
Every Form D from the week of Oct 26, 2026 · All recent filings in Louisiana · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what 28bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.